US Patent Issued to Arbor Biotechnologies on Nov. 4 for "CRISPR RNA targeting enzymes and systems and uses thereof" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,203, issued on Nov. 4, was assigned to Arbor Biotechnologies Inc. (Cambridge, Mass.).

"CRISPR RNA targeting enzymes and systems and uses thereof" was invented by David R. Cheng (Boston), David A. Scott (San Francisco), Winston X. Yan (Brookline, Mass.) and Shaorong Chong (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of a nucleic acid."

The patent was filed on Nov. 8, 2021, under Ap...